Oppenheimer & CO Inc Teva Pharmaceutical Industries LTD Transaction History

Oppenheimer & CO Inc

  • $6.52 Billion
  • Q4 2024

A detailed history of Oppenheimer & CO Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Oppenheimer & CO Inc holds 10,278 shares of TEVA stock, worth $167,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,278
Previous 32,402 68.28%
Holding current value
$167,017
Previous $583,000 61.23%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$16.43 - $22.77 $363,497 - $503,763
-22,124 Reduced 68.28%
10,278 $226,000
Q3 2024

Nov 05, 2024
BUY
$15.81 - $18.96 $208,929 - $250,556
13,215 Added 68.87%
32,402 $583,000
Q2 2024

Aug 07, 2024
BUY
$12.78 - $17.4 $72,398 - $98,570
5,665 Added 41.89%
19,187 $311,000
Q1 2024

May 06, 2024
BUY
$10.67 - $14.43 $12,590 - $17,027
1,180 Added 9.56%
13,522 $190,000
Q4 2023

Feb 13, 2024
SELL
$8.12 - $10.63 $8,712 - $11,405
-1,073 Reduced 8.0%
12,342 $128,000
Q3 2023

Nov 07, 2023
SELL
$7.48 - $10.7 $33,323 - $47,668
-4,455 Reduced 24.93%
13,415 $136,000
Q2 2023

Aug 02, 2023
SELL
$7.2 - $9.47 $325,173 - $427,693
-45,163 Reduced 71.65%
17,870 $134,000
Q1 2023

May 10, 2023
SELL
$8.36 - $11.37 $62,808 - $85,422
-7,513 Reduced 10.65%
63,033 $557,000
Q4 2022

Feb 07, 2023
SELL
$7.95 - $9.48 $53,320 - $63,582
-6,707 Reduced 8.68%
70,546 $643,000
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $24,010 - $41,825
3,500 Added 4.75%
77,253 $623,000
Q2 2022

Aug 08, 2022
SELL
$7.38 - $10.4 $133,393 - $187,980
-18,075 Reduced 19.68%
73,753 $554,000
Q1 2022

May 12, 2022
BUY
$7.33 - $9.39 $325,034 - $416,380
44,343 Added 93.38%
91,828 $861,000
Q4 2021

Feb 02, 2022
SELL
$7.9 - $10.19 $38,789 - $50,032
-4,910 Reduced 9.37%
47,485 $381,000
Q3 2021

Nov 12, 2021
SELL
$8.38 - $10.18 $74,498 - $90,500
-8,890 Reduced 14.51%
52,395 $511,000
Q2 2021

Aug 03, 2021
SELL
$9.9 - $11.56 $91,436 - $106,768
-9,236 Reduced 13.1%
61,285 $606,000
Q1 2021

May 10, 2021
SELL
$10.34 - $12.81 $56,580 - $70,096
-5,472 Reduced 7.2%
70,521 $814,000
Q4 2020

Feb 11, 2021
SELL
$8.61 - $11.04 $239,091 - $306,569
-27,769 Reduced 26.76%
75,993 $734,000
Q3 2020

Nov 13, 2020
BUY
$8.57 - $12.69 $18,879 - $27,956
2,203 Added 2.17%
103,762 $935,000
Q2 2020

Aug 11, 2020
SELL
$8.12 - $13.12 $462,661 - $747,551
-56,978 Reduced 35.94%
101,559 $1.25 Million
Q1 2020

May 08, 2020
BUY
$6.69 - $13.45 $422,399 - $849,219
63,139 Added 66.18%
158,537 $1.43 Million
Q4 2019

Feb 07, 2020
SELL
$6.53 - $10.72 $29,463 - $48,368
-4,512 Reduced 4.52%
95,398 $935,000
Q3 2019

Oct 31, 2019
SELL
$6.16 - $9.6 $83,597 - $130,281
-13,571 Reduced 11.96%
99,910 $687,000
Q2 2019

Aug 09, 2019
SELL
$8.12 - $15.72 $34,713 - $67,203
-4,275 Reduced 3.63%
113,481 $1.05 Million
Q1 2019

Apr 24, 2019
SELL
$15.58 - $20.01 $138,397 - $177,748
-8,883 Reduced 7.01%
117,756 $1.85 Million
Q4 2018

Jan 29, 2019
SELL
$14.59 - $23.84 $23,913 - $39,073
-1,639 Reduced 1.28%
126,639 $1.95 Million
Q3 2018

Oct 26, 2018
BUY
$21.06 - $25.65 $251,603 - $306,440
11,947 Added 10.27%
128,278 $2.76 Million
Q2 2018

Aug 10, 2018
BUY
$16.77 - $24.71 $191,647 - $282,385
11,428 Added 10.89%
116,331 $2.83 Million
Q1 2018

May 01, 2018
SELL
$16.68 - $22.07 $308,980 - $408,824
-18,524 Reduced 15.01%
104,903 $1.79 Million
Q4 2017

Feb 07, 2018
SELL
$11.23 - $19.1 $305,927 - $520,322
-27,242 Reduced 18.08%
123,427 $2.34 Million
Q3 2017

Nov 09, 2017
BUY
$15.41 - $32.17 $2.32 Million - $4.85 Million
150,669
150,669 $2.65 Million

Others Institutions Holding TEVA

# of Institutions
671
Shares Held
571M
Call Options Held
21.1M
Put Options Held
9.94M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email